Fast and Accurate EEG Medical Devices – $20 Million Debt Secured
A medical device that informs a patient of epileptic status by wearing a headband to a seizure patient and quickly and accurately diagnosing the amount of electrical activity.
FDA-approved 24/7 EEG portable monitoring device. Results that used to take 4 hours can be checked within 10 minutes to prevent permanent damage through rapid treatment.
Ceribell
Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective.
The company creates and validates an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications.
General Information
- Headquarters : San Francisco, CA
- Founders : Josef Parvizi, Xingjuan Chao
- Categories : Biotechnology, Health Care, Health Diagnostics, Medical Device
- Founded : 2014
Funding
- Investors: Horizon Technology Finance
- Funding Rounds (2) - $55M
- May 1, 2020 Debt Financing / $20M
- Sep 25, 2018 Series B / $35M
Source: Ceribell
👉• Web: https://www.ceribell.com/
👉• Video: Ceribell Inc - YouTube
0 Comments